Threshold Pharmaceuticals (THLD)

Add to Watchlists Create an Alert
5.44 -0.14  -2.51%   NASDAQ May 22, 8:00PM BATS Real time Currency in USD

Threshold Pharmaceuticals Interest Expense:

0.00 for March 31, 2013
View Full Chart

Threshold Pharmaceuticals Interest Expense Chart

    Threshold Pharmaceuticals Historical Interest Expense Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.00
    Dec. 31, 2012 0.00
    Sept. 30, 2012 0.00
    June 30, 2012 0.00
    March 31, 2012 108.39M
    Dec. 31, 2011 0.00
    Sept. 30, 2011 0.00
    June 30, 2011 0.00
    March 31, 2011 0.939M
    Dec. 31, 2010 0.00
    Sept. 30, 2010 0.00
    June 30, 2010 0.00
    March 31, 2010 0.223M
    Dec. 31, 2009 0.00
    Sept. 30, 2009 0.00
    June 30, 2009 0.00
    March 31, 2009 1.411M
    Dec. 31, 2008 0.00
       
    Sept. 30, 2008 0.00
    June 30, 2008 0.00
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro

    About Interest Expense

    When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.

    A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.

    YCharts includes both operating interest expense and non-operating interest expense in our numbers.
    Learn More

    Get data for

    THLD Interest Expense Benchmarks

    Companies
    Merrimack Pharmaceuticals 0.553M
    ZIOPHARM Oncology 0.00
    Clovis Oncology 0.00

    THLD Interest Expense Rankings

    Overall 99th percentile
    51 of 8006
    Sector 98th percentile
    9 of 686 in Healthcare
    Industry 97th percentile
    5 of 248 in Biotechnology

    THLD Interest Expense Range, Past 5 Years

    Minimum 0.00 Jun 2008
    Maximum 108.39M Mar 2012
    Average 5.548M